Advances and Challenges of Liposome Assisted Drug Delivery
- PMID: 26648870
- PMCID: PMC4664963
- DOI: 10.3389/fphar.2015.00286
Advances and Challenges of Liposome Assisted Drug Delivery
Abstract
The application of liposomes to assist drug delivery has already had a major impact on many biomedical areas. They have been shown to be beneficial for stabilizing therapeutic compounds, overcoming obstacles to cellular and tissue uptake, and improving biodistribution of compounds to target sites in vivo. This enables effective delivery of encapsulated compounds to target sites while minimizing systemic toxicity. Liposomes present as an attractive delivery system due to their flexible physicochemical and biophysical properties, which allow easy manipulation to address different delivery considerations. Despite considerable research in the last 50 years and the plethora of positive results in preclinical studies, the clinical translation of liposome assisted drug delivery platforms has progressed incrementally. In this review, we will discuss the advances in liposome assisted drug delivery, biological challenges that still remain, and current clinical and experimental use of liposomes for biomedical applications. The translational obstacles of liposomal technology will also be presented.
Keywords: accelerated blood clearance; biological challenges; complement activation–related pseudoallergy; drug delivery; lipid-based drug delivery system; liposomes; nanotechnology; translation.
Figures
Similar articles
-
Liposomes: Biomedical Applications.Chonnam Med J. 2021 Jan;57(1):27-35. doi: 10.4068/cmj.2021.57.1.27. Epub 2021 Jan 25. Chonnam Med J. 2021. PMID: 33537216 Free PMC article. Review.
-
Design of liposomes as drug delivery system for therapeutic applications.Int J Pharm. 2021 May 15;601:120571. doi: 10.1016/j.ijpharm.2021.120571. Epub 2021 Apr 2. Int J Pharm. 2021. PMID: 33812967 Review.
-
Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.Curr Drug Metab. 2022;23(9):678-692. doi: 10.2174/1389200223666220609141459. Curr Drug Metab. 2022. PMID: 35692131 Review.
-
The use of lipid-based nanocarriers for targeted pain therapies.Front Pharmacol. 2013 Nov 21;4:143. doi: 10.3389/fphar.2013.00143. Front Pharmacol. 2013. PMID: 24319430 Free PMC article. Review.
-
Unravelling the in vivo dynamics of liposomes: Insights into biodistribution and cellular membrane interactions.Life Sci. 2024 Jun 1;346:122616. doi: 10.1016/j.lfs.2024.122616. Epub 2024 Apr 8. Life Sci. 2024. PMID: 38599316 Review.
Cited by
-
Microfluidic technologies for lipid vesicle generation.Lab Chip. 2024 Sep 26. doi: 10.1039/d4lc00380b. Online ahead of print. Lab Chip. 2024. PMID: 39323383 Free PMC article. Review.
-
Natural Food Components as Biocompatible Carriers: A Novel Approach to Glioblastoma Drug Delivery.Foods. 2024 Sep 4;13(17):2812. doi: 10.3390/foods13172812. Foods. 2024. PMID: 39272576 Free PMC article. Review.
-
Late-onset major depressive disorder: exploring the therapeutic potential of enhancing cerebral brain-derived neurotrophic factor expression through targeted microRNA delivery.Transl Psychiatry. 2024 Sep 3;14(1):352. doi: 10.1038/s41398-024-02935-7. Transl Psychiatry. 2024. PMID: 39227372 Free PMC article. Review.
-
Nanoparticles as a Novel Platform for Cardiovascular Disease Diagnosis and Therapy.Int J Nanomedicine. 2024 Aug 27;19:8831-8846. doi: 10.2147/IJN.S474888. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39220195 Free PMC article. Review.
-
Review on Hyaluronic Acid Functionalized Sulfur and Nitrogen Co-Doped Graphene Quantum Dots Nano Conjugates for Targeting of Specific Type of Cancer.Adv Pharm Bull. 2024 Jul;14(2):266-277. doi: 10.34172/apb.2024.043. Epub 2024 Mar 17. Adv Pharm Bull. 2024. PMID: 39206392 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources